Hollyce Hartzler joined Tevard Biosciences in 2023 as a Senior Research Associate II in Molecular Biology with over 15 years of experience in academia, large biotech, and startups. After graduating with a B.S. from Saint Louis University, Hollyce has worked on a wide variety of topics including pox virology at Saint Louis University, transplant immunology at Washington University in Saint Louis, and cell line engineering at MilliporeSigma. In 2019 she moved to Boston to join a stealth mode startup in the Flagship Pioneering ecosystem and worked most recently at Ribon Therapeutics on their PARP7 inhibitor.